150 related articles for article (PubMed ID: 19615464)
1. Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes.
Uyama T; Jin XH; Tsuboi K; Tonai T; Ueda N
Biochim Biophys Acta; 2009 Dec; 1791(12):1114-24. PubMed ID: 19615464
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins.
Han BG; Cho JW; Cho YD; Kim SY; Yoon HJ; Song HK; Cheong HK; Jeon YH; Lee DK; Lee S; Lee BI
Protein Expr Purif; 2010 May; 71(1):103-7. PubMed ID: 20100577
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional characterization of tumor suppressors TIG3 and H-REV107.
Wei H; Wang L; Ren X; Yu W; Lin J; Jin C; Xia B
FEBS Lett; 2015 May; 589(11):1179-86. PubMed ID: 25871522
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type.
Uyama T; Morishita J; Jin XH; Okamoto Y; Tsuboi K; Ueda N
J Lipid Res; 2009 Apr; 50(4):685-93. PubMed ID: 19047760
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of the N-terminal catalytic domain of human H-REV107--a novel circular permutated NlpC/P60 domain.
Ren X; Lin J; Jin C; Xia B
FEBS Lett; 2010 Oct; 584(19):4222-6. PubMed ID: 20837014
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the acyltransferase activity of lecithin:retinol acyltransferase-like proteins.
Golczak M; Kiser PD; Sears AE; Lodowski DT; Blaner WS; Palczewski K
J Biol Chem; 2012 Jul; 287(28):23790-807. PubMed ID: 22605381
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway.
Wang CH; Shyu RY; Wu CC; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM
J Biomed Sci; 2014 May; 21(1):36. PubMed ID: 24884338
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Phospholipase A/Acyltransferase-3 with Pex19p: A POSSIBLE INVOLVEMENT IN THE DOWN-REGULATION OF PEROXISOMES.
Uyama T; Kawai K; Kono N; Watanabe M; Tsuboi K; Inoue T; Araki N; Arai H; Ueda N
J Biol Chem; 2015 Jul; 290(28):17520-34. PubMed ID: 26018079
[TBL] [Abstract][Full Text] [Related]
9. Enzymological analysis of the tumor suppressor A-C1 reveals a novel group of phospholipid-metabolizing enzymes.
Shinohara N; Uyama T; Jin XH; Tsuboi K; Tonai T; Houchi H; Ueda N
J Lipid Res; 2011 Nov; 52(11):1927-35. PubMed ID: 21880860
[TBL] [Abstract][Full Text] [Related]
10. Cloning and functional characterization of the HRASLS2 gene.
Shyu RY; Hsieh YC; Tsai FM; Wu CC; Jiang SY
Amino Acids; 2008 Jun; 35(1):129-37. PubMed ID: 18163183
[TBL] [Abstract][Full Text] [Related]
11. Generation of N-acylphosphatidylethanolamine by members of the phospholipase A/acyltransferase (PLA/AT) family.
Uyama T; Ikematsu N; Inoue M; Shinohara N; Jin XH; Tsuboi K; Tonai T; Tokumura A; Ueda N
J Biol Chem; 2012 Sep; 287(38):31905-19. PubMed ID: 22825852
[TBL] [Abstract][Full Text] [Related]
12. Comparative analyses of isoforms of the calcium-independent phosphatidylethanolamine N-acyltransferase PLAAT-1 in humans and mice.
Hussain Z; Uyama T; Kawai K; Rahman IA; Tsuboi K; Araki N; Ueda N
J Lipid Res; 2016 Nov; 57(11):2051-2060. PubMed ID: 27623847
[TBL] [Abstract][Full Text] [Related]
13. Involvement of phospholipase A/acyltransferase-1 in N-acylphosphatidylethanolamine generation.
Uyama T; Inoue M; Okamoto Y; Shinohara N; Tai T; Tsuboi K; Inoue T; Tokumura A; Ueda N
Biochim Biophys Acta; 2013 Dec; 1831(12):1690-701. PubMed ID: 23994608
[TBL] [Abstract][Full Text] [Related]
14. Regulation of peroxisomal lipid metabolism by catalytic activity of tumor suppressor H-rev107.
Uyama T; Ichi I; Kono N; Inoue A; Tsuboi K; Jin XH; Araki N; Aoki J; Arai H; Ueda N
J Biol Chem; 2012 Jan; 287(4):2706-18. PubMed ID: 22134920
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12.
Husmann K; Sers C; Fietze E; Mincheva A; Lichter P; Schäfer R
Oncogene; 1998 Sep; 17(10):1305-12. PubMed ID: 9771974
[TBL] [Abstract][Full Text] [Related]
16. 1H, 13C, and 15N resonance assignments of the N-terminal domain of human TIG3.
Wang L; Yu W; Ren X; Lin J; Jin C; Xia B
Biomol NMR Assign; 2012 Oct; 6(2):201-3. PubMed ID: 22290676
[TBL] [Abstract][Full Text] [Related]
17. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.
Sers C; Husmann K; Nazarenko I; Reich S; Wiechen K; Zhumabayeva B; Adhikari P; Schröder K; Gontarewicz A; Schäfer R
Oncogene; 2002 Apr; 21(18):2829-39. PubMed ID: 11973642
[TBL] [Abstract][Full Text] [Related]
18. Molecular interaction between K-Ras and H-REV107 in the Ras signaling pathway.
Han CW; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2017 Sep; 491(2):257-264. PubMed ID: 28743497
[TBL] [Abstract][Full Text] [Related]
19. Ameliorating effect of lipo-ATRA treatment on the expression of TIG3 and its suppressing effect on PPARγ gene expression in lung cancer animal model.
Ravichandran R; Viswanathan S; Berlin Grace VM; Bonati L; Narayanan J
Mol Cell Biochem; 2019 Oct; 460(1-2):105-112. PubMed ID: 31300983
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene.
DiSepio D; Ghosn C; Eckert RL; Deucher A; Robinson N; Duvic M; Chandraratna RA; Nagpal S
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14811-5. PubMed ID: 9843971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
